Thrilled to announce that the Accel-Heal Solo electrical stimulation wound therapy device won bronze in the Most Innovate Dressing or Device category of the Journal of Wound Care (JWC) World Union of Wound Healing Societies (WUWHS) Awards, held in Abu Dhabi on 3 March 2022.
We are delighted to announce the launch of Accel-Heal in France. Patients in France suffering from painful and hard-to-heal wounds can now benefit from Accel-Heal’s unique 12-day electrical stimulation therapy.
The incidence of hard-to-heal wounds, those that take longer than 4-weeks to heal, is growing globally, leading to an increasing burden to national healthcare systems.
A panel of experts in electrical stimulation therapy discussed some of their greatest success stories using Accel-Heal to assist in the care of painful and hard-to-heal wounds.
Accel-Heal Technologies Limited is thrilled to announce the launch of the next generation of its innovative therapy device to improve outcomes in recalcitrant wounds.
Watch key opinion leaders in wound care demystify the concept of electrical stimulation, explaining how it can benefit those with hard-to-heal wounds.
Accel-Heal Commercial Director, Paul McKenna, introduces a webinar on the use of electrical stimulation therapy to stimulate wound healing after the recent news that Singapore and Australia have approved use of the devices.
In the paper “Electrical stimulation for pain reduction in hard-to-heal wound healing” a literature review was carried out to identify the impact of electrical stimulation wound therapy on chronic wound outcomes.